ExlService Holdings, Inc.
EXLS scores 55.0 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.
No material penalties applied. EXLS ranks #426 based on its factor profile and ML signal alignment.
These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.
| Stock | Score | P/E | Rev Growth | Margin | Mkt Cap |
|---|---|---|---|---|---|
| EXLS | 55.0 | 20.0 | 12.7% | 11.9% | $4.9B |
| MPWR | 84.8 | 91.7 | 21.2% | 81.0% | $57.1B |
| ZM | 84.2 | 18.0 | 3.1% | 21.7% | $27.7B |
| NVDA | 80.6 | 45.2 | 114.2% | 55.8% | $4.5T |
| CRUS | 79.7 | 19.1 | 6.0% | 17.5% | $7.4B |
| ASML | 77.8 | 48.1 | 15.6% | 29.4% | $546.0B |
| IDCC | 77.4 | 31.8 | -4.0% | 48.8% | $9.7B |
| CSCO | 77.1 | 27.6 | 5.3% | 18.0% | $303.6B |
| RMBS | 75.5 | 48.3 | 20.7% | 32.3% | $11.0B |
| DBX | 75.3 | 13.9 | 1.9% | 17.7% | $6.4B |
| FSLR | 75.0 | 17.3 | 26.7% | 30.7% | $24.2B |
| SIMO | 74.7 | 9.2 | 10.2% | 13.8% | $4.5B |
| ADI | 74.3 | 74.1 | 16.9% | 20.6% | $165.1B |
| AAPL | 72.5 | 33.1 | 6.4% | 27.0% | $3.9T |
| OLED | 72.5 | 27.0 | 12.4% | 34.3% | $5.9B |
| AMAT | 72.3 | 36.4 | 4.4% | 24.7% | $281.7B |
| Sector Average | 47.4 | 87.8 | 14.8% | -110.0% | — |
ExlService Holdings, Inc. operates as a data analytics, and digital operations and solutions company in the United States and internationally. It operates through Insurance, Healthcare, Analytics, and Emerging Business segments. The company provides digital operations and solutions and analytics-driven services across the insurance industry in areas, such as claims processing, premium and benefit administration, agency management, account reconciliation, policy research, underwriting support, new business acquisition, policy servicing, premium audit, surveys, billing and collection, commercial and residential survey, and customer service using digital technology, artificial intelligence, machine learning, and advanced automation; digital customer acquisition services using a software-as-a-service delivery model through LifePRO and LISS platforms; subrogation services; and Subrosource software platform, an end-to-end subrogation platform. It also offers CareRadius, an integrated care management offering; and health care services related to care management, utilization management, disease management, payment integrity, revenue optimization and customer engagement to healthcare payers, providers, pharmacy benefit managers, and life sciences organizations. Further, it offers predictive and prescriptive analytics in the areas of customer acquisition and lifecycle management, risk underwriting and pricing, operational effectiveness, credit and operational risk monitoring and governance, payment integrity and care management, and data management. The company was founded in 1999 and is headquartered in New York, New York.
Stock is in a downtrend below the 200-day moving average. Price is below both the 50-day and 200-day SMAs, indicating sustained selling pressure.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $543M | $530M | $514M | $501M |
| Gross Profit | $210M | $204M | $194M | $193M |
| Operating Income | $78M | $76M | $81M | $78M |
| Net Income | $60M | $58M | $66M | $67M |
| EPS (Diluted) | $0.38 | $0.36 | $0.40 | $0.40 |
| Gross Margin | 38.6% | 38.5% | 37.7% | 38.6% |
| Operating Margin | 14.4% | 14.4% | 15.8% | 15.7% |
| Net Margin | 11.1% | 11.0% | 12.8% | 13.3% |
| Year | Low | High | Range | Status |
|---|---|---|---|---|
| 2021 | $15.92 | $29.19 | 58.8% | Wide |
| 2022 | $22.43 | $38.24 | 52.1% | Wide |
| 2023 | $25.17 | $35.94 | 35.2% | Wide |
| 2024 | $28.16 | $47.37 | 50.9% | Wide |
| 2025 | $37.30 | $52.43 | 33.7% | Moderate |
Growth estimates have been dampened based on technical and fundamental signals. This is a post-hoc adjustment to prevent overly optimistic projections for stocks showing declining momentum or deteriorating fundamentals.
Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.